Robert E. Slayton
Impact in
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment
- Surgery top 10%
- Testicular diseases and treatments
- Bladder and Urothelial Cancer Treatments
Papers in
- Surgery 19
- Testicular diseases and treatments 12
- Bladder and Urothelial Cancer Treatments 3
-
- Ovarian cancer diagnosis and treatment 10
- Co-authors
- Charles P. Perlia (5 shared papers)Arthur H. Rossof (3 shared papers)John A. Blessing (12 shared papers)Steven G. Silverberg (3 shared papers)Hugh M. Shingleton (3 shared papers)Philip Bonomi (8 shared papers)Robert C. Park (1 shared paper)William T. Creasman (1 shared paper)
- Journals
- Cancer (7 papers)Gynecologic Oncology (6 papers)Investigational New Drugs (3 papers)International Journal of Radiation Oncology*Biology*Physics (1 paper)Clinical Pharmacology & Therapeutics (1 paper)
- Partner nations
- United StatesSingapore
In The Last Decade
Robert E. Slayton
36 papers receiving 712 citations
Peers
Comparison fields: 5 of 83
- Reproductive Medicine 222
- Surgery 357
- Neurology 122
- Oncology 213
- Obstetrics and Gynecology 53
Countries citing papers authored by Robert E. Slayton
This map shows the geographic impact of Robert E. Slayton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert E. Slayton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert E. Slayton more than expected).
Fields of papers citing papers by Robert E. Slayton
This network shows the impact of papers produced by Robert E. Slayton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert E. Slayton. The network helps show where Robert E. Slayton may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert E. Slayton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1972 | 130 | |
| 2 | 1985 | 111 | |
| 3 | 1978 | 70 | |
| 4 | 1985 | 60 | |
| 5 | 1971 | 59 | |
| 6 | 1981 | 52 | |
| 7 | 1978 | 52 | |
| 8 | 1971 | 41 | |
| 9 | Megestrol acetate used as primary hormonal therapy in stage D prostatic cancer. | 1985 | 29 |
| 10 | 1985 | 20 | |
| 11 | Management of germ cell and stromal tumors of the ovary. | 1984 | 18 |
| 12 | 1991 | 17 | |
| 13 | 1981 | 12 | |
| 14 | 1989 | 12 | |
| 15 | Doxorubicin and cisplatin for recurrent or metastatic squamous cell carcinoma of the head and neck. | 1984 | 11 |
| 16 | Phase II trial adriamycin and cis-dichlorodiammineplatinum(II) in squamous cell, ovarian, and testicular carcinomas. | 1978 | 11 |
| 17 | 1983 | 10 | |
| 18 | 1983 | 10 | |
| 19 | 1988 | 9 | |
| 20 | 1973 | 9 |
About Robert E. Slayton
Robert E. Slayton is a scholar working on Surgery, Reproductive Medicine, Pulmonary and Respiratory Medicine, Oncology and Molecular Biology, having authored 37 papers that have together received 802 indexed citations. Recurring topics across this work include Testicular diseases and treatments (12 papers), Ovarian cancer diagnosis and treatment (10 papers), Neuroblastoma Research and Treatments (4 papers), Cancer therapeutics and mechanisms (4 papers), Endometrial and Cervical Cancer Treatments (4 papers), Prostate Cancer Treatment and Research (4 papers), Cancer Treatment and Pharmacology (3 papers) and Bladder and Urothelial Cancer Treatments (3 papers). The work is most often cited by research in Reproductive Medicine (222 citations), Surgery (357 citations), Neurology (122 citations), Oncology (213 citations) and Obstetrics and Gynecology (53 citations). Robert E. Slayton has collaborated with scholars based in United States and Singapore. Frequent co-authors include Charles P. Perlia, Arthur H. Rossof, John A. Blessing, Steven G. Silverberg, Hugh M. Shingleton, Philip Bonomi, Robert C. Park, William T. Creasman, Paul Elson and Janet Wolter. Their work appears in journals such as Cancer, Gynecologic Oncology, Investigational New Drugs, International Journal of Radiation Oncology*Biology*Physics and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.